Institutional Ownership
Arcutis Biotherapeutics Inc
CUSIP 03969K108COMARQTQ1 2026
Institutional Holders
260
13F filers
Shares Held
124.41M
Aggregate institutional
Institutional Value
$2.89B
Q1 2026
Net New Holders
-12
32 new · 44 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions32
Increased104
Decreased86
Sold out44
Institutional Holders
260 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 12.33M | $290.42M | +363.0K | Added |
| 2 | Frazier Life Sciences Management, L.P. | 9.87M | $232.64M | 0 | Held |
| 3 | Blackrock, Inc. | 9.20M | $216.76M | +100.8K | Added |
| 4 | Rubric Capital Management LP | 8.27M | $194.88M | 0 | Held |
| 5 | State Street Corp | 6.30M | $148.34M | +807.9K | Added |
| 6 | Polar Capital Holdings PLC | 5.67M | $133.51M | +110.8K | Added |
| 7 | Jennison Associates LLC | 4.98M | $117.35M | −1.78M | Reduced |
| 8 | Gilder Gagnon Howe & Co LLC | 4.30M | $101.40M | −149.8K | Reduced |
| 9 | Morgan Stanley | 4.22M | $99.40M | −121.3K | Reduced |
| 10 | Ubs Group AG | 3.33M | $78.44M | +85.8K | Added |
250 more institutional holders on Premium
See every fund holding Arcutis Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders